Global Mammography Market Driven by Increased Breast Cancer Prevalence
|
By MedImaging International staff writers Posted on 18 Apr 2019 |
The growth of the global mammography market is being driven by the rising prevalence of breast cancer, technological advancements in breast imaging, and investments by various organizations in breast cancer screening campaigns. The high-incidence and mortality rates for breast cancer among women aged 60 years and above who account for almost 78% of all breast cancer-related deaths represent a huge unmet need for breast cancer diagnostics. The rising number of breast cancer incidents and mortality cases is expected to increase the demand for mammography and consequently, boost the growth of the global mammography market over the coming years.
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
On the basis of the technology used, conventional screen-film mammography (SFM) with high-spatial resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are witnessing a shift to newer systems which use digital receptors and computers, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. Digital mammography systems also offer the added advantages of soft-copy image displays and soft-copy reading, which can be easily transferred, as well as significantly lower radiation exposure as compared to analog systems.
Hence, digital mammography is becoming the preferred choice of screening, despite the new technology costing six times more than conventional systems. Full-field digital mammography is the most common form of digital mammography employed and offers potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. The major market players are also focusing on technological advancements and reducing the side effects of the procedures. These advantages of digital mammography are expected to aid the growth of the global mammography market over the coming years.
Geographically, North America holds the largest share of the global mammography market and is expected to maintain its leading position over the coming years. The growth of the North American mammography market is expected to be driven by the rising prevalence of breast cancer, better healthcare infrastructure, and increase in funding activity for research in breast cancer in the region.
Related Links:
Research and Markets
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
On the basis of the technology used, conventional screen-film mammography (SFM) with high-spatial resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are witnessing a shift to newer systems which use digital receptors and computers, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. Digital mammography systems also offer the added advantages of soft-copy image displays and soft-copy reading, which can be easily transferred, as well as significantly lower radiation exposure as compared to analog systems.
Hence, digital mammography is becoming the preferred choice of screening, despite the new technology costing six times more than conventional systems. Full-field digital mammography is the most common form of digital mammography employed and offers potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. The major market players are also focusing on technological advancements and reducing the side effects of the procedures. These advantages of digital mammography are expected to aid the growth of the global mammography market over the coming years.
Geographically, North America holds the largest share of the global mammography market and is expected to maintain its leading position over the coming years. The growth of the North American mammography market is expected to be driven by the rising prevalence of breast cancer, better healthcare infrastructure, and increase in funding activity for research in breast cancer in the region.
Related Links:
Research and Markets
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







